Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

InspireMD Inc (NYSE MKT LLC:NSPR)

0.102
Delayed Data
As of Sep 23
 +0.0015 / +1.49%
Today’s Change
0.10
Today|||52-Week Range
2.12
-88.41%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$3.1M

Company Description

InspireMD, Inc. engages in the development and commercialization of the stent platform technology MGuard, which provides embolic protection in stenting procedures by placing a micronet mesh sleeve over a stent. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Boston, MA.

Contact Information

InspireMD, Inc.
321 Columbus Avenue
Boston Massachusetts 02116
P:(857) 305-2410
Investor Relations:

Employees

Shareholders

Individual stakeholders13.23%
Other institutional1.36%
Mutual fund holders0.49%

Top Executives

James J. BarryPresident, Chief Executive Officer & Director
Craig ShoreCFO, Secretary, Treasurer & CAO
Chaim Shaul LotanChief Medical Officer
Gwen K. BameVice President-Corporate Development
David BlossomVice President-Global Marketing & Strategy